|
1
|
Alzabin S, Bhardwaj N, Kiefer F,
Sawasdikosol S and Burakoff S: Hematopoietic progenitor kinase 1 is
a negative regulator of dendritic cell activation. J Immunol.
182:6187–6194. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhou G, Boomer JS and Tan TH: Protein
phosphatase 4 is a positive regulator of hematopoietic progenitor
kinase 1. J Biol Chem. 279:49551–49561. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siligardi G, Ruzza P, Hussain R, Cesaro L,
Brunati AM, Pinna LA and Donella-Deana A: The SH3 domain of HS1
protein recognizes lysine-rich polyproline motifs. Amino Acids.
42:1361–1370. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sawasdikosol S, Pyarajan S, Alzabin S,
Matejovic G and Burakoff SJ: Prostaglandin E2 activates HPK1 kinase
activity via a PKA-dependent pathway. J Biol Chem. 282:34693–34699.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu SK, Smith CA, Arnold R, Kiefer F and
McGlade CJ: The adaptor protein Gads (Grb2-related adaptor
downstream of Shc) is implicated in coupling hemopoietic progenitor
kinase-1 to the activated TCR. J Immunol. 165:1417–1426. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shui JW, Boomer JS, Han J, Xu J, Dement
GA, Zhou G and Tan TH: Hematopoietic progenitor kinase 1 negatively
regulates T cell receptor signaling and T cell-mediated immune
responses. Nat Immunol. 8:84–91. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brenner D, Golks A, Kiefer F, Krammer PH
and Arnold R: Activation or suppression of NFkappaB by HPK1
determines sensitivity to activation-induced cell death. EMBO J.
24:4279–4290. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brenner D, Golks A, Becker M, Müller W,
Frey CR, Novak R, Melamed D, Kiefer F, Krammer PH and Arnold R:
Caspase-cleaved HPK1 induces CD95L-independent activation-induced
cell death in T and B lymphocytes. Blood. 110:3968–3977. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ling P, Meyer CF, Redmond LP, Shui JW,
Davis B, Rich RR, Hu MC, Wange RL and Tan TH: Involvement of
hematopoietic progenitor kinase 1 in T cell receptor signaling. J
Biol Chem. 276:18908–18914. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arnold R, Patzak IM, Neuhaus B,
Vancauwenbergh S, Veillette A, Van Lint J and Kiefer F: Activation
of hematopoietic progenitor kinase 1 involves relocation,
autophosphorylation, and transphosphorylation by protein kinase D1.
Mol Cell Biol. 25:2364–2383. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Alzabin S, Pyarajan S, Yee H, Kiefer F,
Suzuki A, Burakoff S and Sawasdikosol S: Hematopoietic progenitor
kinase 1 is a critical component of prostaglandin E2-mediated
suppression of the anti-tumor immune response. Cancer Immunol
Immunother. 59:419–429. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Königsberger S, Peckl-Schmid D, Zaborsky
N, Patzak I, Kiefer F and Achatz G: HPK1 associates with SKAP-HOM
to negatively regulate Rap1-mediated B-lymphocyte adhesion. PLoS
One. 5(pii): e124682010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Anafi M, Kiefer F, Gish GD, Mbamalu G,
Iscove NN and Pawson T: SH2/SH3 adaptor proteins can link tyrosine
kinases to a Ste20-related protein kinase, HPK1. J Biol Chem.
272:27804–27811. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ling P, Yao Z, Meyer CF, Wang XS, Oehrl W,
Feller SM and Tan TH: Interaction of hematopoietic progenitor
kinase 1 with adapter proteins Crk and CrkL leads to synergistic
activation of c-Jun N-terminal kinase. Mol Cell Biol. 19:1359–1368.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sawasdikosol S, Russo KM and Burakoff SJ:
Hematopoietic progenitor kinase 1 (HPK1) negatively regulates
prostaglandin E2-induced fos gene transcription. Blood.
101:3687–3689. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou G, Lee SC, Yao Z and Tan TH:
Hematopoietic progenitor kinase 1 is a component of transforming
growth factor beta-induced c-Jun N-terminal kinase signaling
cascade. J Biol Chem. 274:13133–13138. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang W, Zhou G, Hu MC, Yao Z and Tan TH:
Activation of the hematopoietic progenitor kinase-1
(HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK)
pathway by transforming growth factor beta (TGF-beta)-activated
kinase (TAK1), a kinase mediator of TGF beta signal transduction. J
Biol Chem. 272:22771–22775. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nagata Y, Kiefer F, Watanabe T and
Todokoro K: Activation of hematopoietic progenitor kinase-1 by
erythropoietin. Blood. 93:3347–3354. 1999.PubMed/NCBI
|
|
19
|
Arnold R, Frey CR, Müller W, Brenner D,
Krammer PH and Kiefer F: Sustained JNK signaling by proteolytically
processed HPK1 mediates IL-3 independent survival during monocytic
differentiation. Cell Death Differ. 14:568–575. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen YR and Tan TH: Inhibition of the
c-Jun N-terminal kinase (JNK) signaling pathway by curcumin.
Oncogene. 17:173–178. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Balakireva M, Rossé C, Langevin J, Chien
YC, Gho M, Gonzy-Treboul G, Voegeling-Lemaire S, Aresta S, Lepesant
JA, Bellaiche Y, et al: The Ral/exocyst effector complex counters
c-Jun N-terminal kinase-dependent apoptosis in Drosophila
melanogaster. Mol Cell Biol. 26:8953–8963. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ito Y, Pandey P, Sathyanarayana P, Ling P,
Rana A, Weichselbaum R, Tan TH, Kufe D and Kharbanda S: Interaction
of hematopoietic progenitor kinase 1 and c-Abl tyrosine kinase in
response to genotoxic stress. J Biol Chem. 276:18130–18138. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu MC, Wang Yp, Qiu WR, Mikhail A, Meyer
CF and Tan TH: Hematopoietic progenitor kinase-1 (HPK1) stress
response signaling pathway activates IkappaB kinases
(IKK-alpha/beta) and IKK-beta is a developmentally regulated
protein kinase. Oncogene. 18:5514–5524. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen YR, Meyer CF, Ahmed B, Yao Z and Tan
TH: Caspase-mediated cleavage and functional changes of
hematopoietic progenitor kinase 1 (HPK1). Oncogene. 18:7370–7377.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Arnold R, Liou J, Drexler HC, Weiss A and
Kiefer F: Caspase-mediated cleavage of hematopoietic progenitor
kinase 1 (HPK1) converts an activator of NFkappaB into an inhibitor
of NFkappaB. J Biol Chem. 276:14675–14684. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schulze-Luehrmann J, Santner-Nanan B, Jha
MK, Schimpl A, Avots A and Serfling E: Hematopoietic progenitor
kinase 1 supports apoptosis of T lymphocytes. Blood. 100:954–960.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen YR and Tan TH: The c-Jun N-terminal
kinase pathway and apoptotic signaling (Review). Int J Oncol.
16:651–662. 2000.PubMed/NCBI
|
|
28
|
Brenner D, Krammer PH and Arnold R:
Concepts of activated T cell death. Crit Rev Oncol Hematol.
66:52–64. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Krammer PH, Arnold R and Lavrik IN: Life
and death in peripheral T cells. Nat Rev Immunol. 7:532–542. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang H, Song X, Logsdon C, Zhou G, Evans
DB, Abbruzzese JL, Hamilton SR, Tan TH and Wang H:
Proteasome-mediated degradation and functions of hematopoietic
progenitor kinase 1 in pancreatic cancer. Cancer Res. 69:1063–1070.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Q, Long H, Liao J, Zhao M, Liang G,
Wu X, Zhang P, Ding S, Luo S and Lu Q: Inhibited expression of
hematopoietic progenitor kinase 1 associated with loss of jumonji
domain containing 3 promoter binding contributes to autoimmunity in
systemic lupus erythematosus. J Autoimmun. 37:180–189. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang X, Li JP, Kuo HK, Chiu LL, Dement GA,
Lan JL, Chen DY, Yang CY, Hu H and Tan TH: Down-regulation of B
cell receptor signaling by hematopoietic progenitor kinase 1
(HPK1)-mediated phosphorylation and ubiquitination of activated B
cell linker protein (BLNK). J Biol Chem. 287:11037–11048. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stoeckman AK, Baechler EC, Ortmann WA,
Behrens TW, Michet CJ and Peterson EJ: A distinct inflammatory gene
expression profile in patients with psoriatic arthritis. Genes
Immun. 7:583–591. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Batliwalla FM, Li W, Ritchlin CT, Xiao X,
Brenner M, Laragione T, Shao T, Durham R, Kemshetti S, Schwarz E,
et al: Microarray analyses of peripheral blood cells identifies
unique gene expression signature in psoriatic arthritis. Mol Med.
11:21–29. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen-Deutsch X, Kutner A, Harrison JS and
Studzinski GP: The pan-caspase inhibitor Q-VD-OPh has anti-leukemia
effects and can interact with vitamin D analogs to increase HPK1
signaling in AML cells. Leuk Res. 36:884–888. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen-Deutsch X and Studzinski GP: Dual
role of hematopoietic progenitor kinase 1 (HPK1) as a positive
regulator of 1α,25-dihydroxyvitamin D-induced differentiation and
cell cycle arrest of AML cells and as a mediator of vitamin D
resistance. Cell Cycle. 11:1364–1373. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang Y, Luo H, Li Y, Chen T, Wu S and Yang
L: hsa-miR-96 up-regulates MAP4K1 and IRS1 and may function as a
promising diagnostic marker in human bladder urothelial carcinomas.
Mol Med Rep. 5:260–265. 2012.PubMed/NCBI
|
|
38
|
Qian Y, Takeuchi S, Dugu L, Tsuji G, Xie
L, Nakahara T, Takahara M, Moroi Y, Tu YT and Furue M:
Hematopoietic progenitor kinase 1, mitogen-activated
protein/extracellular signal-related protein kinase kinase kinase 1
and phosphomitogen-activated protein kinase kinase 4 are
overexpressed in extramammary Paget disease. Am J Dermatopathol.
33:681–686. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang HS, Matthews CP, Clair T, Wang Q,
Baker AR, Li CC, Tan TH and Colburn NH: Tumorigenesis suppressor
Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase
kinase 1 expression to suppress colon carcinoma cell invasion. Mol
Cell Biol. 26:1297–1306. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sawasdikosol S, Zha R, Yang B and Burakoff
S: HPK1 as a novel target for cancer immunotherapy. Immunol Res.
54:262–265. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jakob SM, Pick R, Brechtefeld D, Nussbaum
C, Kiefer F, Sperandio M and Walzog B: Hematopoietic progenitor
kinase 1 (HPK1) is required for LFA-1-mediated neutrophil
recruitment during the acute inflammatory response. Blood.
121:4184–4194. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Geisberger R, Prlic M,
Achatz-Straussberger G, Oberndorfer I, Luger E, Lamers M, Crameri
R, Appenzeller U, Wienands J, Breitenbach M, et al: Phage display
based cloning of proteins interacting with the cytoplasmic tail of
membrane immunoglobulins. Dev Immunol. 9:127–134. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Buday L: Membrane-targeting of signalling
molecules by SH2/SH3 domain-containing adaptor proteins. Biochim
Biophys Acta. 1422:187–204. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wilkinson B, Wang H and Rudd CE: Positive
and negative adaptors in T-cell signalling. Immunology.
111:368–374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ma W, Xia C, Ling P, Qiu M, Luo Y, Tan TH
and Liu M: Leukocyte-specific adaptor protein Grap2 interacts with
hematopoietic progenitor kinase 1 (HPK1) to activate JNK signaling
pathway in T lymphocytes. Oncogene. 20:1703–1714. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Han A, Saijo K, Mecklenbräuker I,
Tarakhovsky A and Nussenzweig MC: Bam32 links the B cell receptor
to ERK and JNK and mediates B cell proliferation but not survival.
Immunity. 19:621–632. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Boomer JS and Tan TH: Functional
interactions of HPK1 with adaptor proteins. J Cell Biochem.
95:34–44. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Thome M, Charton JE, Pelzer C and
Hailfinger S: Antigen receptor signaling to NF-kappaB via CARMA1,
BCL10, and MALT1. Cold Spring Harb Perspect Biol. 2:a0030042010.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Brenner D, Brechmann M and Röhling S,
Tapernoux M, Mock T, Winter D, Lehmann WD, Kiefer F, Thome M,
Krammer PH and Röhling S: Phosphorylation of CARMA1 by HPK1 is
critical for NF-kappaB activation in T cells. Proc Natl Acad Sci
USA. 106:14508–14513. 2009; View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chen YR, Kori R, John B and Tan TH:
Caspase-mediated cleavage of actin-binding and
SH3-domain-containing proteins cortactin, HS1, and HIP-55 during
apoptosis. Biochem Biophys Res Commun. 288:981–989. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Patzak IM, Königsberger S, Suzuki A, Mak
TW and Kiefer F: HPK1 competes with ADAP for SLP-76 binding and via
Rap1 negatively affects T-cell adhesion. Eur J Immunol.
40:3220–3225. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ruzza P, Siligardi G, Donella-Deana A,
Calderan A, Hussain R, Rubini C, Cesaro L, Osler A, Guiotto A,
Pinna LA and Borin G: 4-Fluoroproline derivative peptides: Effect
on PPII conformation and SH3 affinity. J Pept Sci. 12:462–471.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Le Bras S, Foucault I, Foussat A, Brignone
C, Acuto O and Deckert M: Recruitment of the actin-binding protein
HIP-55 to the immunological synapse regulates T cell receptor
signaling and endocytosis. J Biol Chem. 279:15550–15560. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Han J, Shui JW, Zhang X, Zheng B, Han S
and Tan TH: HIP-55 is important for T-cell proliferation, cytokine
production, and immune responses. Mol Cell Biol. 25:6869–6878.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Han J, Kori R, Shui JW, Chen YR, Yao Z and
Tan TH: The SH3 domain-containing adaptor HIP-55 mediates c-Jun
N-terminal kinase activation in T cell receptor signaling. J Biol
Chem. 278:52195–52202. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ensenat D, Yao Z, Wang XS, Kori R, Zhou G,
Lee SC and Tan TH: A novel src homology 3 domain-containing adaptor
protein, HIP-55, that interacts with hematopoietic progenitor
kinase 1. J Biol Chem. 274:33945–33950. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Liou J, Kiefer F, Dang A, Hashimoto A,
Cobb MH, Kurosaki T and Weiss A: HPK1 is activated by lymphocyte
antigen receptors and negatively regulates AP-1. Immunity.
12:399–408. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Oehrl W, Kardinal C, Ruf S, Adermann K,
Groffen J, Feng GS, Blenis J, Tan TH and Feller SM: The germinal
center kinase (GCK)-related protein kinases HPK1 and KHS are
candidates for highly selective signal transducers of Crk family
adapter proteins. Oncogene. 17:1893–1901. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lewitzky M, Harkiolaki M, Domart MC, Jones
EY and Feller SM: Mona/Gads SH3C binding to hematopoietic
progenitor kinase 1 (HPK1) combines an atypical SH3 binding motif,
R/KXXK, with a classical PXXP motif embedded in a polyproline type
II (PPII) helix. J Biol Chem. 279:28724–28732. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Shen R, Ouyang YB, Qu CK, Alonso A,
Sperzel L, Mustelin T, Kaplan MH and Feng GS: Grap negatively
regulates T-cell receptor-elicited lymphocyte proliferation and
interleukin-2 induction. Mol Cell Biol. 22:3230–3236. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Lasserre R, Cuche C, Blecher-Gonen R,
Libman E, Biquand E, Danckaert A, Yablonski D, Alcover A and Di
Bartolo V: Release of serine/threonine-phosphorylated adaptors from
signaling microclusters down-regulates T cell activation. J Cell
Biol. 195:839–853. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Sauer K, Liou J, Singh SB, Yablonski D,
Weiss A and Perlmutter RM: Hematopoietic progenitor kinase 1
associates physically and functionally with the adaptor proteins B
cell linker protein and SLP-76 in lymphocytes. J Biol Chem.
276:45207–45216. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Tsuji S, Okamoto M, Yamada K, Okamoto N,
Goitsuka R, Arnold R, Kiefer F and Kitamura D: B cell adaptor
containing src homology 2 domain (BASH) links B cell receptor
signaling to the activation of hematopoietic progenitor kinase 1. J
Exp Med. 194:529–539. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yu J, Riou C, Davidson D, Minhas R, Robson
JD, Julius M, Arnold R, Kiefer F and Veillette A: Synergistic
regulation of immunoreceptor signaling by SLP-76-related adaptor
Clnk and serine/threonine protein kinase HPK-1. Mol Cell Biol.
21:6102–6112. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Burns JC, Corbo E, Degen J, Gohil M,
Anterasian C, Schraven B, Koretzky GA, Kliche S and Jordan MS: The
SLP-76 Src homology 2 domain is required for T cell development and
activation. J Immunol. 187:4459–4466. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wang X, Li JP, Chiu LL, Lan JL, Chen DY,
Boomer J and Tan TH: Attenuation of T cell receptor signaling by
serine phosphorylation-mediated lysine 30 ubiquitination of SLP-76
protein. J Biol Chem. 287:34091–34100. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Di Bartolo V, Montagne B, Salek M,
Jungwirth B, Carrette F, Fourtane J, Sol-Foulon N, Michel F,
Schwartz O, Lehmann WD and Acuto O: A novel pathway down-modulating
T cell activation involves HPK-1-dependent recruitment of 14-3-3
proteins on SLP-76. J Exp Med. 204:681–691. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Utting O, Sedgmen BJ, Watts TH, Shi X,
Rottapel R, Iulianella A, Lohnes D and Veillette A: Immune
functions in mice lacking Clnk, an SLP-76-related adaptor expressed
in a subset of immune cells. Mol Cell Biol. 24:6067–6075. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Girardin SE and Yaniv M: A direct
interaction between JNK1 and CrkII is critical for Rac1-induced JNK
activation. EMBO J. 20:3437–3446. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kiefer F, Tibbles LA, Anafi M, Janssen A,
Zanke BW, Lassam N, Pawson T, Woodgett JR and Iscove NN: HPK1, a
hematopoietic protein kinase activating the SAPK/JNK pathway. EMBO
J. 15:7013–7025. 1996.PubMed/NCBI
|
|
71
|
Hu MC, Qiu WR, Wang X, Meyer CF and Tan
TH: Human HPK1, a novel human hematopoietic progenitor kinase that
activates the JNK/SAPK kinase cascade. Genes Dev. 10:2251–2264.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Marshall AJ, Niiro H, Lerner CG, Yun TJ,
Thomas S, Disteche CM and Clark EA: A novel B lymphocyte-associated
adaptor protein, Bam32, regulates antigen receptor signaling
downstream of phosphatidylinositol 3-kinase. J Exp Med.
191:1319–1332. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Hehner SP, Hofmann TG, Dienz O, Droge W
and Schmitz ML: Tyrosine-phosphorylated Vav1 as a point of
integration for T-cell receptor- and CD28-mediated activation of
JNK, p38, and interleukin-2 transcription. J Biol Chem.
275:18160–18171. 2000. View Article : Google Scholar : PubMed/NCBI
|
